Guidance validates the comprehensive approach Bracco has advanced for more than three decades NEEDHAM, Mass., April 13, 2026 /PRNewswire/ -- Bracco, the market leader in diagnostic imaging and the ...
The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. In the first study to describe the magnitude of coronary microvascular collateral ...
Please provide your email address to receive an email when new articles are posted on . Teleflex’s percutaneous transluminal coronary angioplasty perfusion balloon catheter has received FDA 510(k) ...
The emerging advantages of positron-emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease (CAD) diagnosis and assessment of cardiovascular event risk has prompted ...
GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary artery disease (CAD), compared to SPECT MPI, ...
The much-anticipated Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission tomography myocardial perfusion imaging agent for the detection of coronary artery disease, ...
Hybrid cardiac imaging techniques enhance coronary artery disease diagnosis, physiologic assessment, risk stratification, and ...
DENVER, April 22, 2022 – A new study examines the effect of rapid infusion of 2meq/kg of sodium bicarbonate (NaHCO3) in an ovine model on gas exchange and coronary and cerebral perfusion in the ...
Cleveland-based University Hospitals Harrington Heart & Vascular Institute has become the first site in Ohio to clinically administer Flyrcado for the detection of coronary artery disease and arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results